Translational Bioethics

The field of "Translational Bioethics" explores ethical and regulatory issues in pre-clinical and clinical research as well as in big data research. In empirical studies translational bioethics analyses, among other things, how legal requirements or ethical recommendations (e.g. informed consent, risk-benefit-assessments, or patient engagement) are applied in research practice. On the basis of study results and in close cooperation with researchers, patient representatives and other relevant stakeholders, proposals are then developed on how these guidelines and recommendations can be implemented more effectively and efficiently in practice.

BRAVO: Benchmarking Academic Institutions´ Contributions to Increasing Value and Reducing Waste in Biomedical Research

BRAVO examines the extent to which Germany's medical faculties consider and promote various aspects of quality of biomedical research. The aim of the project is to raise awareness of researchers and faculties of the world-wide "Increasing Value" debate, and to support the implementation of incentive schemes to promote the registration, publication, open access and reproduction of biomedical studies.

Further information


CEO-sys | Building a Covid-19 evidence ecosystem to improve knowledge management and translation

QUEST Center is participating in the CEO-sys project as part of the National University Medicine research network funded by the German Federal Ministry of Education and Research (BMBF), which aims to strengthen the research activities of German university medicine to cope with the Covid-19 pandemic.

Further information (in German)


Extent, Predictors, and Management of Publication Bias in Animal ResearCh (EMBARC)

EMBARC examines to what extent, in what form and in what time previously approved animal testing applications have published their results and study methods. EMBARC will then use expert interviews on publication bias to examine the attitudes and approaches of the various stakeholders in the context of animal research.

Further informationen


FairBBank

Biobanks are collections of samples from human origin, such as tissue or blood samples, which are combined with clinically relevant data. The samples are stored as a long-term resource for future research projects. Samples stored in biobanks can be valuable for different research purposes in biomedicine. The objective of FairBBank (2014-2017) was the analysis of challenges and potentials for a fair allocation of samples in biobank based research.

Further information


GEENGOV: Governance of Research using Genom Editing Technology in Humans (closed)

GEENGOV is concerned with issues of regulating research that employs modern genome editing (e.g. CRISPR-Cas9) technology on somatic cells of humans. The project focuses on three important questions: (1) How can risk-benefit-assessments of GEEN-studies on human somatic cells be conducted systematically and professionally? (2) How can we ensure valid informed consent is provided by patients and participants of studies or so called “Heilversuche” employing such technology? (3) Is there a need for additional regulation by the state or other institutions (governance) or are established regulatory mechanisms and institutions sufficient?

Further information


Good Justification Practice

The project Good Justification Practice investigates how research decisions in translational biomedicine can be justified prospectively in order to meet bioethical requirements. What is necessary to be able to assess in advance whether probability statements about the expected success of a research project in translational biomedicine are well-founded? Which criteria can be used to accomplish this?

Further information


HiGHmed

The „HiGHmed“ consortium is funded by the Federal Ministry of Education and Research (BMBF) under the Medical Informatics Initiative. HiGHmed involves a dedicated Work Package “Ethics and Stakeholder”. This Work Package undertakes interdisciplinary research on ethical, policy and social issues with regard to Big Data and the collection, linking, and use of patient data in medical research and health care. Central aims of the Work Package are the development of normative frameworks and practice-oriented recommendations for governance solutions. The involvement of various stakeholders is a central concern. The results will not only support HiGHmed, but target also national and international debates.

Further information


PRECOPE - Preparedness and Response for Ethical Challenges in Human Subject Research during COVID-19 and similar PandEmics

The PRECOPE study aims to address the need to “articulate and translate existing ethical standards to salient issues in COVID-19”, highlighted by the WHO research roadmap for COVID-19, by preparing for and responding to the practice-/decision-oriented challenges in translating ethical principles into concrete human subject research on COVID-19.

Further information


Publication of results from clinical trials (IntoValue)

One of our first projects, the IntoValue project, is concerned with the publication of clinical trials. The publication of all results from clinical trials is an important component for improving biomedical research and reducing the amount of unused research results. 

Further information


Quality and reporting of Patient Engagement

In this project, we analyse the quality and reporting of Patient Engagement in health research.

Further Information


QUEST Clinical trial reporting manual

Most universities in the EU are currently failing to upload clinical trial results onto registries, leading to research waste and incomplete outcome reporting. Universities are often unclear about how to (a) upload the results of old trials, and (b) set up systems that ensure timely results posting going forward. This creates a barrier to improved performance. The aim of the project is to draw together the experiences and lessons learnt by front-runner universities that have successfully tackled the problem, and develop a hands-on manual for other universities that wish to do the same.

Further information


STRUCTURES

STRUCTURES (Structure and Transparency in Translational Research) focuses on normative and practical challenges in two intertwined tools for governing translational research: A) a more explicit and structured risk-benefit analysis in early human studies and B) a more comprehensive and standardized registration and reporting of preclinical animal research.

Further information


TrackValue - Tracking and Improving Value Indicators

TrackValue aims to improve biomedical studies at the Charité by developing relevant value indicators, assessing Charité’s performance on these indicators and giving feedback to individual researchers.

Further information